Press Releases

OMAHA, Neb., May 08, 2024 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (OTCQX: EXOD) (the “Company” or “Exodus”) today announced that it was informed by the NYSE American that the exchange has delayed the Company’s listing until the Staff of the Securities and Exchange Commission completes its review of Exodus’ registration statement, which went effective on April 28, 2024. The NYSE American previously informed Exodus that its shares of Class A common stock,... (continue reading...)

Renova Has Prioritized Two Primary Regulatory Pathways Where It Is Poised to Launch Pivotal Human Trials for Its Promising Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus

CARLSBAD, CA / ACCESSWIRE / May 8, 2024 / Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene... (continue reading...)

LONDON, May 8, 2024 /PRNewswire/ -- OLED monitor display shipments significantly increased in 2023, following an upsurge of 415% year-over-year (YoY), according to Omdia's Monitor Display & OEM Market Tracker. This trend is set to continue with Omdia forecasting a 123% YoY increase in 2024, reaching 1.84 million units, driven by industry leaders Samsung Display and LG Display.

... (continue reading...)

WILMINGTON, Del.--(BUSINESS WIRE)-- The LYCRA Company, a global leader in developing innovative, sustainable solutions for the apparel and personal care industries, announced today that it has signed a letter of intent with Dairen Chemical Corporation (DCC) to convert QIRA®—the next generation of 1,4 butanediol (BDO)—into low-impact PTMEG, the main ingredient in patented bio-derived LYCRA® fiber. Dairen will be the first company in the world to mass produce... (continue reading...)

NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Anavex securities between June 21, 2021 and January... (continue reading...)